Health & Biotech
MGC Pharmaceuticals (ASX: MXC) has changed its name to Argent Biopharma - RGT (ASX: RGT).
Below are the previous articles from MGC Pharmaceuticals (ASX: MXC):
RELATED STOCKHEAD STORIES
Health & Biotech
MGC Pharma share price soars after CannEpil+ scores UK-first import deal
Health & Biotech
ASX Health Stocks: Cannabis play Cronos scoots 19% higher on merger news, Telix gets FDA nod for clinical trial
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
News
Weed Week: Cannabis-infused drinks market could reach US$2.8 billion by 2025
News
ASX Small Cap Lunch Wrap: Who feels good after deworming today?
Health & Biotech
ASX Health Stocks: Neuroscientific pockets $25m R&D incentive, MGC Pharma jumps 15% on India approval for COVID-19 drug
Health & Biotech
MGC Pharma’s lead product CimetrA one step closer to a registered medicine for COVID-19 patients in India
News
Closing Bell: ASX closes slightly lower, still notches up weekly gain
News
ASX Small Cap Lunch Wrap: Who’s trying not to blink today?
News
10 at 10: These ASX stocks are doing the best amidst the rough markets this morning
News
Market Highlights and 5 ASX Small Caps to watch on Friday
Health & Biotech
MGC Pharma signs US distribution deal, lands access to the world’s largest healthcare market
Health & Biotech
MGC Pharma delivers record sales quarter, makes progress on critical milestones
Stockhead TV
Q-Wrapz: Oriel Morrison interviews Roby Zomer, Managing Director of MGC Pharma (ASX:MXC)
Health & Biotech
MGC Pharma set to commence Phase III clinical trial on CimetrA to treat COVID-19 patients
Health & Biotech
Weed Week: Amazon all-in on marijuana; free joints for jabs and Creso Pharma dual-listed in US
Health & Biotech
